Federal Register / Vol. 62, No. 29 / Wednesday, February 12, 1997 / Notices 6551

Health Resources and Services

Administration

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

Periodically, the Health Resources

and Services Administration (HRSA)

publishes abstracts of information

collection requests under review by the

Office of Management and Budget, in

compliance with the Paperwork

Reduction Act of 1995 (44 U.S.C.

Chapter 35). To request a copy of the

clearance requests submitted to OMB for

review, call the HRSA Reports

Clearance Office on (301)–443–1129.

The following request has been

submitted to the Office of Management

and Budget for review under the

Paperwork Reduction Act of 1995:

Voluntary Partner Surveys to

Implement Executive Order 12862 in

the Health Resources and Services

Administration—NEW

In response to Executive Order 12862,

‘‘Setting Customer Service Standards’’,

the Health Resources and Services

Administration (HRSA) is proposing to

conduct voluntary customer surveys of

its ‘‘partners’’ to assess strengths and

weaknesses in program services. A

generic approval is being requested from

OMB to conduct the partner surveys.

HRSA partners are typically State or

local governments, health care facilities,

health care consortia, health care

providers, and researchers.

Partner surveys to be conducted by

HRSA might include, for example, mail

or telephone surveys of grantees to

determine satisfaction with a technical

assistance contractor, or in-class

evaluation forms completed by

providers who receive training from

HRSA grantees, to measure satisfaction

with the training experience. Results of

these surveys will be used to plan and

redirect resources and efforts as needed

to improve service. Focus groups may

also be used to gain partner input into

the design of mail and telephone

surveys. Focus groups, in-class

evaluation forms, mail surveys, and

telephone surveys are expected to be the

preferred methodologies.

A generic approval will permit HRSA

to conduct a limited number of partner

surveys without a full-scale OMB

review of each survey. If generic

approval is granted, information on each

individual partner survey will not be

published in the Federal Register.

Anyone wishing to receive information

on individual partner surveys as they

are developed should contact the HRSA

Reports Clearance Officer at (301)443–

1129.

An estimate of annual burden is

shown below.

Type of Survey Number of

respondents

Responses per

respondent

Avg. burden/

response (hrs.)

Total hours of

burden

In-class evaluations ................................................................................ 40,000 1 0.05 2,000

Mail/telephone surveys ........................................................................... 12,000 1 0.25 3,000

Focus groups .......................................................................................... 50 1 1.5 75

Total ............................................................................................. 52,050 1 0.10 5,075

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Virginia Huth, Human Resources and

Housing Branch, Office of Management

and Budget, New Executive Office

Building, Room 10235, Washington,

D.C. 20503.

Dated: February 6, 1997.

J. Henry Montes,

Director, Office of Policy and Information

Coordination.

[FR Doc. 97–3531 Filed 2–11–97; 8:45 am]

BILLING CODE 4160–15–P

National Institutes of Health

National Institute of Environmental

Health Sciences; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:

Name of Committee: Environmental Health

Sciences Review Committee.

Date: March 24–26, 1997.

Time: 8:30 a.m. to Adjournment.

Place: National Institute of Environmental

Health Sciences, South Campus, Building

101, Conference Room B, Research Triangle

Park, North Carolina.

Contact Person: Dr. Ethel B. Jackson,

Scientific Review Administrator, P.O. Box

12233, Research Triangle Park, NC 27709,

(919) 541–7826.

Purpose: To review and evaluate grant

applications.

The meeting will be closed in accordance

with the provisions set froth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.113, Biological Response to

Environmental Health Hazards; 93.114,

Applied Toxicological Research and Testing;

93.115, Biometry and Risk Estimation;

93.894, Research and Manpower

Development, National Institutes of Health)

Dated: February 5, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–3418 Filed 2–11–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

advisory committee meeting of the

National Institute of General Medical

Sciences Special Emphasis Panel:

Committee name: Pharmacokinetics and

Pharmacodynamics.

Date: Febuary 26, 1997.

Time: 8:00 a.m.—until conclusion

(approximately 4 hours).

Place: Stanyan Park Hotel, 750 Stanyan

Street, San Francisco, CA 94117.

Contact Person: Irene B. Glowinski, Ph.D.,

Scientific Review Administrator, NIGMS,

Office of Scientific Review, 45 Center Drive,

Room 1AS–13J, Bethesda, MD 20892–6200,

301–594–2772 or 301–594–3663.

Purpose: To review and evaluate grant

applications. This meeting will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

The discussions of these applications could

reveal confidential trade secrets of

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.